CenterBook Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
103,151
+67,919
+193% +$8.22M 0.54% 33
2026
Q1
$5.76M Buy
+35,232
New +$5.42M 0.31% 90
2025
Q2
Sell
-15,991
Closed -$1.22M 551
2025
Q1
$1.22M Buy
15,991
+6,600
+70% +$505K 0.08% 285
2024
Q4
$648K Sell
9,391
-71,945
-88% -$5.18M 0.04% 389
2024
Q3
$5.94M Buy
+81,336
New +$6M 0.37% 82

Other funds holding INSM

CenterBook Partners's INSM Position: Q2 2026 in Review

CenterBook Partners increased its Insmed (INSM) stake by 193% in Q2 2026, buying an estimated $8.22M and bringing the position to 103,151 shares worth $11M. The position accounts for 0.54% of the portfolio, ranked #33.

CenterBook Partners first reported a position in INSM in Q3 2024 and has held it in 5 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • CenterBook Partners held 103,151 shares of Insmed worth $11M as of Q2 2026.
  • CenterBook Partners bought 67,919 Insmed shares in Q2 2026, an estimated $8.22M.
  • Insmed made up 0.54% of CenterBook Partners's portfolio in Q2 2026, its #33 holding.
  • CenterBook Partners first reported a position in Insmed in Q3 2024 and has held it in 5 quarters since.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.